Atlas Trials

Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis

Clinical trial NCT00975637 · COMPLETED

Trial details

NCT number
NCT00975637
Sponsor
Bausch Health Americas, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Psoriasis
Start date
2009-12-01
Primary completion
2010-07-01
Enrollment
198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.